Although current therapeutic strategies like platelet transfusions, thrombopoietin receptor agonists, and glucocorticoids are used to manage thrombocytopenia, their limitations, including side effects and restricted applicability, have driven the search for alternative treatments (Zhang T. et al., 2023). Here, MPL is linked to Thrombocytopenia.